Asia Tech Wire (June 4) -- Chinese tech giant Tencent has taken a stake in hemophilia drug company Gensciences Inc.

Gensciences underwent an industrial and commercial change on Monday, adding Tencent Mobility Limited, a subsidiary of Tencent, and an investment unit under Shanghai Zhangjiang Group Co. as its shareholders.

Founded in 2019, Gensciences is a hemophilia innovative drug company, according to the company's website.

The company currently has four innovative drugs in clinical development and registration review.